People facing cancer deserve better options. At #ESMO26, we’re sharing new and updated clinical data across ovarian, thyroid, lung and breast cancers — from early research through Phase 3 studies. Our work is driven by a goal of helping people live longer and live better, especially in cancers that can be difficult to treat. Read more: https://lnkd.in/egHButQH
Eli Lilly and Company
Pharmaceutical Manufacturing
Indianapolis, Indiana 2,934,201 followers
About us
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- Website
-
http://www.lilly.com/
External link for Eli Lilly and Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Indianapolis, Indiana
- Type
- Public Company
- Specialties
- Pharmaceutical Development, Pharmaceuticals, Biotech, and Biopharmaceuticals
Employees at Eli Lilly and Company
View 58k employees at Eli Lilly and Company
or
Locations
-
Primary
Get directions
Lilly Corporate Center
Indianapolis, Indiana 46285, US
Updates
-
For children and adolescents with ulcerative colitis, every year spent relying on corticosteroids or facing the possibility of surgery can have important implications for growth, development and quality of life. New late-breaking Phase 3 investigational data from our SHINE-2 study showed positive one-year findings in young people with moderately to severely active UC. Explore the full findings presented at #UEGWeek: https://lnkd.in/evYAxwe2
-
New post-hoc analyses from our Phase 3 LUCENT and VIVID studies evaluated multidimensional one-year outcomes in adults with ulcerative colitis and Crohn’s disease, including those with prior biologic failure. Achievement of these outcomes was associated with better quality of life. Explore the data presented at #UEGWeek: https://lnkd.in/erTbuAds
-
Living with metastatic breast cancer (MBC) extends beyond a diagnosis. This Metastatic Breast Cancer Awareness Day, we’re highlighting the experiences of people like Melanie, a mother, caregiver, nurse and national park enthusiast living with MBC. Through her story, Melanie shares a look at the everyday realities of metastatic breast cancer and the moments of calm she finds along the way. Read Melanie’s story: https://lnkd.in/eyhxZmNn #WeAreLilly #BreastCancerAwarenessMonth
-
-
Living with atopic dermatitis (AD) is about more than the symptoms others can see. At #FallClinical26, emerging research is inspiring a broader look at the needs of people with AD and the path forward for dermatology. Hear what’s driving dialogue at this year’s congress. #WeAreLilly
-
People living with psoriasis and obesity manage two chronic conditions that are often viewed through separate treatment lenses. But our understanding of the connection between them continues to grow. At #FallClinical26, a new exploratory analysis showed changes in more psoriasis disease-associated and metabolic biomarkers when both conditions were treated together – potentially pointing to a meaningful relationship between immune and metabolic biology. Read more: https://lnkd.in/eRTtHjtT
-
-
How do you change the course of cardiometabolic health? At #EASD2026 in Milan, we joined researchers, clinicians and advocates to talk about what's possible as science advances and new approaches to care emerge. #WeAreLilly
-
With chronic skin conditions, the burden can be constant, including relentless itch and significant pain that can get in the way of daily routines. At #FallClinical26, we’ll share new research across our dermatology portfolio exploring what progress can mean for people living with conditions such as atopic dermatitis or psoriasis. See what’s ahead: https://lnkd.in/eK9s9CJr
-
The FDA has approved a new indication for our oncology medicine, now available for certain patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. This approval is a major milestone in bringing this meaningful blood cancer treatment to more people. Read more: https://lnkd.in/eJ7A5_c5
-
